Correlation Between Deciphera Pharmaceuticals and Regencell Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Deciphera Pharmaceuticals and Regencell Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Deciphera Pharmaceuticals and Regencell Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Deciphera Pharmaceuticals LLC and Regencell Bioscience Holdings, you can compare the effects of market volatilities on Deciphera Pharmaceuticals and Regencell Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Deciphera Pharmaceuticals with a short position of Regencell Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Deciphera Pharmaceuticals and Regencell Bioscience.

Diversification Opportunities for Deciphera Pharmaceuticals and Regencell Bioscience

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Deciphera and Regencell is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Deciphera Pharmaceuticals LLC and Regencell Bioscience Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regencell Bioscience and Deciphera Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Deciphera Pharmaceuticals LLC are associated (or correlated) with Regencell Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regencell Bioscience has no effect on the direction of Deciphera Pharmaceuticals i.e., Deciphera Pharmaceuticals and Regencell Bioscience go up and down completely randomly.

Pair Corralation between Deciphera Pharmaceuticals and Regencell Bioscience

If you would invest  1,332  in Deciphera Pharmaceuticals LLC on August 24, 2024 and sell it today you would earn a total of  0.00  from holding Deciphera Pharmaceuticals LLC or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy1.56%
ValuesDaily Returns

Deciphera Pharmaceuticals LLC  vs.  Regencell Bioscience Holdings

 Performance 
       Timeline  
Deciphera Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Deciphera Pharmaceuticals LLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Deciphera Pharmaceuticals is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.
Regencell Bioscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regencell Bioscience Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Deciphera Pharmaceuticals and Regencell Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Deciphera Pharmaceuticals and Regencell Bioscience

The main advantage of trading using opposite Deciphera Pharmaceuticals and Regencell Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Deciphera Pharmaceuticals position performs unexpectedly, Regencell Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regencell Bioscience will offset losses from the drop in Regencell Bioscience's long position.
The idea behind Deciphera Pharmaceuticals LLC and Regencell Bioscience Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk